Photopheresis is an extracorporeal photochemotherapy (ECP) used for the treatment of
oncological and autoimmune diseases. Lymphocytes are drawn from the patients by …

Graft versus host disease (GVHD), whether acute or chronic, is a frightening complication of
bone marrow allografts—indeed in many cases it can be life threatening. In chronic GVHD …

Graft-versus-host disease (GVHD)* is a frequent complication of allogeneic bone marrow
transplantation. The potentially beneficial effect of phototherapy for treatment of cutaneous …

Background Extracorporeal photopheresis (ECP) has been shown as active therapy for graft‐
versus‐host disease (GVHD). Study Design and Methods The aim was to ascertain the role …

Advances in posttransplanl immunosuppression have to the present not been able to
prevent the development of graft-versus-host disease (GVHD) in patients given related or …

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

Over the last decades significant advances have been made in the field of donor selection,
alternative transplant sources, immunosuppressive treatment and supportive care, as well …

Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …

Graft-versus-host disease (GVHD) is a frequent complication occurring after allogeneic
hematopoietic stem cell transplantation. It can be classified as acute and chronic GVHD …

Despite significant advances in stem cell manipulation and post-transplant
immunosuppression, chronic graft-versus-host disease (cGVHD) remains a cause of major …